Enterprise Value Chart

Historical Enterprise Value Data

View and export this data back to 2022. Start Trial.
Date Value
November 19, 2026 9.439B
November 18, 2026 9.439B
November 17, 2026 9.439B
November 16, 2026 9.439B
November 13, 2026 9.776B
November 12, 2026 9.776B
November 11, 2026 7.802B
November 10, 2026 7.802B
November 09, 2026 7.802B
November 06, 2026 7.802B
November 05, 2026 7.802B
November 04, 2026 7.802B
November 03, 2026 7.802B
November 02, 2026 7.802B
October 30, 2026 7.802B
October 29, 2026 7.802B
October 28, 2026 7.802B
October 27, 2026 7.802B
October 26, 2026 7.802B
October 23, 2026 7.802B
October 22, 2026 7.802B
October 21, 2026 7.802B
October 20, 2026 7.802B
October 19, 2026 7.802B
October 16, 2026 7.802B
Date Value
October 15, 2026 7.802B
October 14, 2026 7.464B
October 13, 2026 7.464B
October 12, 2026 7.464B
October 09, 2026 7.464B
October 08, 2026 7.464B
October 07, 2026 7.464B
October 06, 2026 7.464B
October 05, 2026 7.464B
October 02, 2026 7.464B
October 01, 2026 7.464B
September 30, 2026 7.464B
September 29, 2026 7.811B
September 28, 2026 7.806B
September 25, 2026 7.806B
September 24, 2026 7.806B
September 23, 2026 7.806B
September 22, 2026 7.806B
September 21, 2026 7.806B
September 18, 2026 7.806B
September 17, 2026 7.806B
September 16, 2026 7.806B
September 15, 2026 7.806B
September 14, 2026 7.806B
September 11, 2026 8.010B

Enterprise Value Definition

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.

Read full definition.

Enterprise Value Range, Past 5 Years

View Enterprise Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Enterprise Value Benchmarks

View Enterprise Value Benchmarks
Start Trial
Novo Nordisk A/S 143.44B
ALK-Abello A/S 7.867B
Xeris Biopharma Holdings, Inc. 3.129B
AstraZeneca PLC 570.36B
ANI Pharmaceuticals, Inc. 1.754B